Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immunobiology

In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors

Bone Marrow Transplantation volume 26, pages 91–96 (2000)Cite this article

Abstract

The potent immunostimulatory cytokine interleukin-2 (IL-2) has been extensively investigated for its potential to induce anti-tumor immunity in a number of tumor models. Only recently the complex interplay of mutually suppressive or supportive cytokines of the IL-2-induced network of cytokines has been better characterized. The aim of this study was to assess which of these in vitro findings are reproducible in vivo in recipients of stem cell transplants (SCT), since in these patients long- lasting impairments in cytokine inducibility have been described. We have therefore studied the kinetics of putative modulators and mediators of IL-2-induced immune activation, namely IL-1β, IL-4, IL-5, IL-10, IL-12, soluble Fas ligand (sFasL), and GM-CSF during IL-2 therapy. All patients were children or adolescents suffering from solid tumors with poor prognosis who received three 5-day courses of high-dose intravenous IL-2 as an adjuvant to their radio-chemotherapy and autologous SCT. While IL-1β, IL-4 and IL-12 were not, and sFasL was only mildly affected by the IL-2 therapy, we observed a consistent and early rise of IL-10, IL-5, and GM-CSF. These increases were rapidly reversible after discontinuation of IL-2 therapy. The inducibility of IL-10, IL-5 and GM-CSF was more pronounced with increasing time from the SCT, and in the third cycle reached an order of magnitude as in high-dose IL-2 patients without SCT. Together with the abundant in vitrodata, these findings may help devise a combination immunotherapy permitting stronger anti-tumor effects, but lesser adverse effects. Bone Marrow Transplantation (2000) 26, 91–96.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Bukowski RM, McLain D, Olencki T et al. Interleukin-2: use in solid tumors Stem Cells (Dayt) 1993 11: 26–32

    Article  CAS  Google Scholar 

  2. Guillaume T, Sekhavat M, Rubinstein DB et al. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Res 1994 54: 3800–3807

    CAS  PubMed  Google Scholar 

  3. Hanenberg H, Dilloo D, Laws HJ et al. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies Exp Hematol 1995 23: 1543–1552

    CAS  PubMed  Google Scholar 

  4. Engelhardt M, Wirth K, Mertelsmann R et al. Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2 Eur J Cancer 1997 33: 1050–1054

    Article  CAS  Google Scholar 

  5. Tilg H, Atkins MB, Dinarello CA et al. Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy Cytokine 1995 7: 734–739

    Article  CAS  Google Scholar 

  6. Dilloo D, Laws HJ, Hanenberg H et al. Induction of two dinstinct natural killer-cell populations, activated T cells and antineoplastic cytokines, by interleukin-2 therapy in children with solid tumors Exp Hematol 1994 22: 1081–1088

    CAS  PubMed  Google Scholar 

  7. Heslop HE, Duncombe AS, Reittie JE et al. Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy of autologous marrow transplantation Br J Haematol 1991 77: 237–244

    Article  CAS  Google Scholar 

  8. Tagliaferri P, Barile C, Caraglia M et al. Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects Am J Clin Oncol 1998 21: 48–53

    Article  CAS  Google Scholar 

  9. Mier JW, Vachino G, van der Meer JW et al. Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients J Clin Immunol 1988 8: 426–436

    Article  CAS  Google Scholar 

  10. Lorenz HM, Hieronymus T, Grünke M et al. Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes Scand J Immunol 1997 45: 660–669

    Article  CAS  Google Scholar 

  11. Saraya KA, Balkwill FR . Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression Br J Cancer 1993 67: 514–521

    Article  CAS  Google Scholar 

  12. Heslop HE, Gottlieb DJ, Bianchi AC et al. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation Blood 1989 74: 1374–1380

    CAS  PubMed  Google Scholar 

  13. Körholz D, Banning U, Bönig H et al. The role of interleukin 10 (IL-10) in IL-15 mediated T-cell responses Blood 1997 90: 4513–4521

    PubMed  Google Scholar 

  14. Guillaume T, Kubin M, Sekhavat M et al. Peripheral blood mononuclear cells from autologous hematopoietic stem cell transplantation recipients produce and respond to IL-12 Bone Marrow Transplant 1996 18: 733–739

    CAS  PubMed  Google Scholar 

  15. Girard D, Gosselin J, Heitz D et al. Effects of interleukin-2 on gene expression in human neutrophils Blood 1995 86: 1170–1176

    CAS  PubMed  Google Scholar 

  16. Schaafsma MR, Falkenburg JHF, Landegent JE et al. In vivo production of interleukin-5, granulocyte–macrophage colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients Blood 1991 78: 1981–1987

    CAS  PubMed  Google Scholar 

  17. VanHaelst Pisani C, Kovach JS, Kita H et al. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer Blood 1991 78: 1538–1544

    CAS  Google Scholar 

  18. Tritarelli E, Rocca E, Testa U et al. Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level Blood 1991 77: 741–749

    CAS  PubMed  Google Scholar 

  19. Sosman JA, Bartemes K, Offord KP et al. Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration Clin Cancer Res 1995 1: 805–812

    CAS  PubMed  Google Scholar 

  20. Burdach St, Jürgens H, Peters C et al. Myeloablative chemo-radiotherapy and hematopoietic stem cell rescue in poor prognosis Ewing's sarcoma J Clin Oncol 1993 11: 1482–1488

    Article  CAS  Google Scholar 

  21. Hempel L, Körholz D, Nussbaum P et al. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation Bone Marrow Transplant 1997 20: 365–368

    Article  CAS  Google Scholar 

  22. Lissoni P, Fumagalli L, Rovelli F et al. In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients Br J Cancer 1998 77: 1957–1960

    Article  CAS  Google Scholar 

  23. Gottlieb DJ, Prentice HG, Heslop HE et al. IL-2 infusion abrogates humoral immune responses in humans Clin Exp Immunol 1992 87: 493–498

    Article  CAS  Google Scholar 

  24. Bönig H, Hannen M, Lex C et al. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo Cancer 1999 86: 340–348

    Article  Google Scholar 

  25. Tilden AB, Dunlap NE . Interleukin-2 augmentation of interleukin-1 and prostaglandin E2 production J Leuk Biol 1989 45: 474–477

    Article  CAS  Google Scholar 

  26. Verheyen J, Bönig H, Kim YM et al. Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells Scand J Immunol 2000 51: 45–51

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Elterninitiative Kinderkrebsklinik eV, Düsseldorf, Germany, and the German Cancer Research Fund, Bonn, Germany. An abstract covering parts of these data was presented at the 1999 ISEH meeting in Monte Carlo, Monaco.

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, Center of Child Health, Heinrich-Heine University Medical Center, Düsseldorf, Germany

    H Bönig, H-J Laws, A Wundes, J Verheyen, M Hannen, Y-M Kim & W Nürnberger

  2. Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Leipzig Medical Center, Leipzig, Germany

    U Banning & D Körholz

Authors
  1. H Bönig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H-J Laws
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Wundes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Verheyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Hannen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y-M Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. U Banning
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W Nürnberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D Körholz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bönig, H., Laws, HJ., Wundes, A. et al. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors. Bone Marrow Transplant 26, 91–96 (2000). https://doi.org/10.1038/sj.bmt.1702431

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702431

Keywords

This article is cited by

Search

Advanced search

Quick links